HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica Zucman-Rossi Selected Research

Focal Nodular Hyperplasia

12/2010[Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
3/2009Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.
7/2008The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
6/2008MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
5/2007Genotype phenotype classification of hepatocellular adenoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica Zucman-Rossi Research Topics

Disease

113Neoplasms (Cancer)
10/2022 - 11/2003
60Hepatocellular Carcinoma (Hepatoma)
10/2022 - 05/2003
30Liver Cell Adenoma (Hepatocellular Adenoma)
11/2022 - 11/2003
24Carcinogenesis
04/2022 - 03/2005
20Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 03/2005
18Liver Neoplasms (Liver Cancer)
04/2022 - 12/2011
12Adenoma (Adenomas)
04/2017 - 05/2003
10Inflammation (Inflammations)
04/2021 - 05/2007
6Fibrosis (Cirrhosis)
01/2022 - 03/2009
6Liver Diseases (Liver Disease)
01/2022 - 01/2016
6Malignant Mesothelioma
01/2020 - 12/2005
5Hemorrhage
11/2022 - 08/2009
5Neoplasm Metastasis (Metastasis)
06/2022 - 04/2012
5Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 05/2003
5Focal Nodular Hyperplasia
12/2010 - 05/2007
3Hepatoblastoma
04/2022 - 01/2019
3Cholangiocarcinoma
01/2022 - 01/2022
3Hypoxia (Hypoxemia)
06/2021 - 03/2015
3Carcinoma (Carcinomatosis)
04/2014 - 03/2006
3Mesothelioma
05/2013 - 12/2005
2Liver Failure
01/2022 - 06/2013
2Infections
04/2021 - 06/2008
2Polyploidy
01/2021 - 01/2020
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2019 - 01/2019
2Hypersensitivity (Allergy)
01/2019 - 02/2010
2Non-alcoholic Fatty Liver Disease
01/2019 - 01/2016
2Genomic Instability
04/2016 - 01/2012
2Hepatitis B
01/2016 - 10/2015
2Lung Neoplasms (Lung Cancer)
05/2013 - 01/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2013 - 01/2010
2Type 2 Diabetes Mellitus (MODY)
03/2005 - 03/2004
2Mason-Type Diabetes
03/2005 - 03/2004
2Type 3 Maturity-Onset Diabetes of the Young
11/2003 - 05/2003
1Acute Intermittent Porphyria (Porphyria, Acute)
10/2022

Drug/Important Bio-Agent (IBA)

27CateninsIBA
11/2022 - 11/2010
23beta CateninIBA
04/2022 - 08/2004
17Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2011
12Messenger RNA (mRNA)IBA
08/2020 - 03/2005
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2005
11Proteins (Proteins, Gene)FDA Link
06/2021 - 01/2009
10Telomerase (Telomerase Reverse Transcriptase)IBA
05/2022 - 03/2005
10Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2002
10Sunitinib (Sutent)FDA Link
01/2022 - 01/2014
10MicroRNAs (MicroRNA)IBA
06/2021 - 06/2008
10Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA
02/2010 - 05/2003
8RNA (Ribonucleic Acid)IBA
04/2022 - 01/2011
7Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2009
7Oral ContraceptivesIBA
04/2014 - 09/2004
6Biological ProductsIBA
04/2022 - 09/2012
6Tyrosine Kinase InhibitorsIBA
01/2022 - 12/2013
5LigandsIBA
01/2021 - 12/2007
5Hepatocyte Nuclear FactorsIBA
05/2017 - 03/2004
4Pharmaceutical PreparationsIBA
01/2022 - 01/2016
4CyclinsIBA
01/2022 - 10/2015
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2021 - 04/2018
4Phosphotransferases (Kinase)IBA
01/2021 - 02/2016
4Small Interfering RNA (siRNA)IBA
12/2018 - 10/2007
4Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA
04/2017 - 03/2009
4AsbestosIBA
05/2013 - 12/2005
3NivolumabIBA
01/2022 - 10/2019
3Formaldehyde (Formol)FDA Link
12/2021 - 11/2005
3ParaffinIBA
12/2021 - 04/2017
3CarcinogensIBA
01/2021 - 12/2005
3Hormones (Hormone)IBA
08/2020 - 09/2004
3Bevacizumab (Avastin)FDA Link
10/2019 - 04/2012
3MethyltransferasesIBA
01/2019 - 10/2015
3Cyclin A2IBA
12/2018 - 10/2015
3LipidsIBA
11/2018 - 05/2007
3Aflatoxin B1 (Aflatoxin B)IBA
11/2017 - 05/2015
3C-Reactive ProteinIBA
04/2017 - 07/2014
2Cadherins (E-Cadherin)IBA
01/2022 - 01/2007
2IpilimumabIBA
01/2022 - 10/2019
2Long Noncoding RNAIBA
10/2021 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2019
2Sorafenib (BAY 43-9006)FDA Link
01/2019 - 05/2011
2Glutamine (L-Glutamine)FDA Link
01/2019 - 12/2016
2pazopanibFDA Link
01/2019 - 01/2018
2Histone MethyltransferasesIBA
01/2019 - 02/2016
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2018 - 10/2017
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2017 - 11/2016
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2016 - 06/2008
2Mitogen-Activated Protein KinasesIBA
11/2016 - 05/2012
2TOR Serine-Threonine KinasesIBA
11/2016 - 04/2015
2Lysine (L-Lysine)FDA Link
03/2016 - 10/2015
2Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2016 - 03/2009
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2013 - 01/2009
2SmokeIBA
05/2013 - 01/2010
2Fatty Acids (Saturated Fatty Acids)IBA
02/2013 - 05/2007
2Adenosine Triphosphatases (ATPase)IBA
12/2009 - 10/2007
2Hepatocyte Nuclear Factor 1IBA
05/2007 - 05/2003
1PorphobilinogenIBA
10/2022
1PorphyrinsIBA
10/2022
1Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
10/2022

Therapy/Procedure

22Therapeutics
06/2022 - 01/2007
5Drug Therapy (Chemotherapy)
10/2021 - 04/2012
5Precision Medicine
01/2020 - 12/2015
5Contraception (Birth Control)
11/2017 - 12/2006
2Metastasectomy
06/2022 - 10/2018
2Immunotherapy
01/2022 - 01/2021
2Biological Therapy
11/2014 - 05/2011